Cambridge Enterprise Ventures is the venture capital arm of Cambridge Enterprise, the commercialisation office of the University of Cambridge. It invests in early-stage technology and life science companies originating from the University's research, managing several funds including the University of Cambridge Venture Fund and the University of Cambridge Enterprise Fund series. The group provides seed funding, follow-on investment, and strategic support to help spin-outs reach commercial viability.
Portfolio 8 Investments
Trismik
Artificial Intelligence, Model Evaluation, Developer Tools
pre-seed
€2.2 M
Sep 2025
Investor
NoBACZ Healthcare
veterinary, animal health, agtech, biomaterials, wound care
unspecified
€4.8 M
Oct 2025
Investor
Cambridge Photon Technology
deeptech, solar, clean energy, photonics
seed
€1.56 M
Nov 2025
Lead
Nu Quantum
quantum computing, deeptech, hardware
series-a
€60 M
Dec 2025
Investor
xWatts
energy management, cleantech, software, built-environment
seed
£1.6 M
Feb 2026
Lead
Seprify
biomaterials, sustainable materials, cosmetics, food & beverage, animal nutrition, coatings, printed electronics
series-a
€13.4 M
Mar 2026
Investor
Semarion
biotechnology, drug discovery, life sciences, cell assay platform
unknown round
$3.8 M
Mar 2026
Investor
Gigaton
artificial intelligence, climate tech, cement, industrial technology
series-a
$26 M
Jun 2026
Investor